Catalyst
Slingshot members are tracking this event:
Roche (RHHBY) Releases New Analyses from Three Phase III Studies of OCREVUS in Relapsing Multiple Sclerosis (RMS) and Primary Progressive Multiple Sclerosis (PPMS)
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| RHHBY |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 14, 2016
Occurred Source:
http://www.roche.com/media/store/releases/med-cor-2016-09-14.htm
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Ectrims, Phase Iii Studies, New Analyses, Ocrevus, Ocrelizumab, Relapsing Multiple Sclerosis, Primary Progressive Multiple Sclerosis
